Tariq Arshad, MD, Senior Manager Commercial Development, Pfizer
John Taylor, Director Business Development, Eurand Pharmaceuticals
Chitakala Kalidas, Ph.D., Director, Global Strategic Regulatory Development, Merck & Co.
Chris Dokomajilar, Business Development Analyst, Recombinant Capital
Janet Linn, Partner, Morgan, Lewis & Bockius LLP
Dr. Kerstin M. Bode-Greuel, Managing Partner, Bioscience Valuation LLC
Mark Ravera, Principal and Managing Director, Strategic Pharma Consulting
Hans F.W. Hoogkamer, Senior Director, Strategic Portfolio Planning, Actelion Pharmaceuticals
Debra K. Bowes, MT, Chevy Chase BioPartners, LLC
Judith Kornfeld, Vice President of Business Development, TransPharma Medical
Paulo Rangel, Partner, ProPharma Partners International
Anita Chawla, Ph.D., Vice President, Analysis Group
Samrat Shenbaga, MBA, MS, Principal, ZS Associates
Scott Lassman, Partner, Wilmer Cutler Pickering Hale and Dorr, LLP
Gus Scheefhals, Chief Business Officer, Avantium Technologies
Craig L. Kephart, Chief Executive Officer, Centric Health Resources
Paul Darling, Ph.D., Associate Principal, ZS Associates